Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001179110-20-011058
Filing Date
2020-11-12
Accepted
2020-11-12 17:55:54
Documents
1
Period of Report
2020-11-04

Document Format Files

Seq Description Document Type Size
1 FORM 4/A - edgar.html 4/A  
1 FORM 4/A - edgar.xml 4/A 8755
  Complete submission text file 0001179110-20-011058.txt   10070
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Issuer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address
SALEKI-GERHARDT AZITA (Reporting) CIK: 0001563545 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35565 | Film No.: 201308332